Itraconazole Terbinafine in pharma franchise in Meghalaya

Itraconazole Terbinafine PCD pharma franchise in Bengaluru

Itraconazole Terbinafine in top pharma company in Bhubaneswar

Itraconazole Terbinafine in pcd pharma supplier in Gangtok

Itraconazole Terbinafine in phama franchise company in india
Itraconazole Terbinafine in phama franchise company in Gandhinagar

Home/Products /itraconazole-200mg-terbinafine-250mg-tablet

About the Product

Description


Italom TRB Tablet is a powerful antifungal medication that combines two effective agents: Itraconazole and Terbinafine. Each tablet contains 200 mg of Itraconazole and 250 mg of Terbinafine, working synergistically to combat a wide range of fungal infections. This combination therapy is particularly beneficial for patients suffering from dermatophyte infections, onychomycosis (fungal nail infections), and systemic fungal infections.

Itraconazole is a triazole antifungal that inhibits the synthesis of ergosterol, a vital component of fungal cell membranes. By disrupting the integrity of the fungal cell membrane, Itraconazole effectively halts the growth and reproduction of fungi. It is particularly effective against various species of fungi, including those responsible for skin, nail, and respiratory infections.

Terbinafine, on the other hand, is an allylamine antifungal that works by inhibiting squalene epoxidase, an enzyme involved in the biosynthesis of ergosterol. This action not only prevents the growth of fungi but also leads to the accumulation of toxic squalene within the fungal cells, further enhancing its antifungal effects. Terbinafine is especially effective against dermatophytes and is commonly used to treat infections of the skin and nails.

The combination of Itraconazole and Terbinafine in Italom TRB Tablet provides a comprehensive approach to treating fungal infections, ensuring a broader spectrum of activity and improved therapeutic outcomes. This makes it an essential option for patients who may not respond adequately to monotherapy.

Manufactured under strict quality control standards, Italom TRB Tablet ensures safety and efficacy. Patients are advised to follow their healthcare provider's instructions regarding dosage and duration of treatment to achieve optimal results while minimizing potential side effects.

While generally well-tolerated, some individuals may experience side effects such as gastrointestinal discomfort, headache, or skin rashes. It is crucial to consult a healthcare professional if any adverse reactions occur or if there are concerns regarding the use of this medication.

Italom TRB Tablet is indicated for the treatment of dermatophyte infections, onychomycosis, and systemic fungal infections.

Italom TRB Tablet is indicated for the treatment of dermatophyte infections, onychomycosis, and systemic fungal infections.

Consult a healthcare provider before using Italom TRB Tablet, especially if you have a history of liver disease or are taking other medications.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Itraconazole 200mg + Terbinafine 250mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the advanced dermatology and antifungal segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on resistant, chronic, and severe fungal infections.

Why should medical distributors include this tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for complex fungal infections under dermatological supervision. Itraconazole is a broad-spectrum antifungal used for systemic and deep fungal infections Terbinafine is highly effective against dermatophytes affecting skin and nails This combination strengthens a premium anti-infective and dermatology portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Itraconazole + Terbinafine Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong dermatologist prescriptions, high demand in chronic fungal infections, repeat therapy usage, hospital and clinic supply, reliable supply chain support, and good margins in specialty antifungal medicines.

How can I become a distributor or franchise partner for this tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.